Oridonin is widely used in medical research due to its potential therapeutic properties. It has shown significant anti-cancer activity by inducing apoptosis and inhibiting the proliferation of various cancer cells, including those in leukemia, breast cancer, and lung cancer. Additionally, oridonin exhibits anti-inflammatory effects, making it a candidate for treating inflammatory diseases. Its antioxidant properties also contribute to its protective effects against oxidative stress-related conditions. Researchers are exploring its potential in combination therapies to enhance its efficacy and reduce side effects in cancer treatment.